U.S. federal trademark · Serial No. 90606612
Custom design, development and optimization of new drug molecules, chemical reagents and biochemical assays; scientific and technological services, namely, custom design and development of new chemical and biological molecules with drug-like properties, in silico computations of molecular interactions, modulation of human leukocyte antigens (HLA) proteins in the field of disease such as autoimmunity; pharmaceutical research and development; scientific research for medical and drug development purposes in the fields of immunotherapy, autoimmune diseases and disorders; development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research services; research in the field of pharmaceuticals for the treatment of immunological diseases and disorders; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.